346
Views
20
CrossRef citations to date
0
Altmetric
Articles

Synthesis, spectral, DFT, and antimicrobial studies of tin(II) and lead(II) complexes with semicarbazone and thiosemicarbazones derived from (2-hydroxyphenyl)(pyrrolidin-1-yl)methanone

, &
Pages 343-353 | Received 02 Apr 2015, Accepted 12 Oct 2015, Published online: 08 Dec 2015
 

Abstract

A new series of metal complexes [M(L)2] (where M = Sn(II), Pb(II), and HL = semicarbazone, thiosemicarbazone or phenylthiosemicarbazone) have been prepared and characterized by elemental analysis, conductance measurements, molecular weight determinations, UV–visible, infrared, and nuclear magnetic resonance (1H-, 13C-, and 119Sn-NMR) spectral studies. Elemental analysis of the metal complexes suggested 1 : 2 (metal–ligand) stoichiometry. Infrared spectra of the complexes agree with coordination to the metal through the nitrogen of the azomethine (>C=N−) and the oxygen/sulfur of the ketonic/thiolic group. Electronic spectra suggest a distorted tetrahedral geometry for all Schiff base complexes. The bond lengths, bond angles, highest occupied molecular orbital, lowest unoccupied molecular orbital, Mulliken atomic charges, and the lowest energy model structure of the complexes have been determined with DFT calculations. Representative Schiff base and its metal chelates have been screened for their in vitro antibacterial activity against four bacteria, Gram-positive (Bacillus cereus, Staphylococcus aureus) and Gram-negative (Escherichia coli, Klebsiella pneumoniae) and four strains of fungus (Penicillium chrysogenum, Aspergillus niger, Rhizopus nigricans, and Alternaria alternata). The metal chelates possess higher antimicrobial activity than the free ligands.

Acknowledgements

The authors are thankful to Dean of the Faculty of Engineering & Technology, Mody University of Science and Technology, Laxmangarh, Sikar, for providing necessary facilities to carry out this research work. They are also thankful to Dr Tejpal Dewa, Department of Microbiology, University of Delhi, for providing antimicrobial screening facilities.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.